Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 6/2019

01-06-2019 | Letter to the Editor

Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia

Authors: Vlatko Pejsa, Marko Lucijanic, Zeljko Jonjic, Zeljko Prka, Gorana Vukorepa

Published in: Annals of Hematology | Issue 6/2019

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Goede V, Fischer K, Busch R, Engelke A, Eichhorst B, Wendtner CM, Chagorova T, de la Serna J, Dilhuydy MS, Illmer T, Opat S, Owen CJ, Samoylova O, Kreuzer KA, Stilgenbauer S, Dohner H, Langerak AW, Ritgen M, Kneba M, Asikanius E, Humphrey K, Wenger M, Hallek M (2014) Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med 370(12):1101–1110. https://​doi.​org/​10.​1056/​NEJMoa1313984 CrossRefPubMed
2.
3.
4.
Metadata
Title
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia
Authors
Vlatko Pejsa
Marko Lucijanic
Zeljko Jonjic
Zeljko Prka
Gorana Vukorepa
Publication date
01-06-2019
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 6/2019
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3552-x

Other articles of this Issue 6/2019

Annals of Hematology 6/2019 Go to the issue

Original Article

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study

Original Article

A novel flow cytometric method for enhancing acute promyelocytic leukemia screening by multidimensional dot-plots

Letter to the Editor

Diffuse large B cell lymphoma and schistosomiasis: a rare simultaneous occurrence

Letter to the Editor

Nivolumab as a safe and effective treatment in an HIV patient with refractory Hodgkin lymphoma

Letter to the Editor

Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation

Letter to the Editor

Ceftazidime-avibactam for gram-negative multidrug-resistant bacteria in hematological patients: a single-center experience

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits